Review



ot-i plus ot-ii peptides  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    GenScript corporation ot-i plus ot-ii peptides
    Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with <t>PBS</t> (Control), with both OT-I and OT-II <t>specific</t> <t>peptides</t> plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
    Ot I Plus Ot Ii Peptides, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ot-i plus ot-ii peptides/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    ot-i plus ot-ii peptides - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25 + Foxp3 - T cells"

    Article Title: IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25 + Foxp3 - T cells

    Journal: eLife

    doi: 10.7554/eLife.62432

    Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
    Figure Legend Snippet: Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.

    Techniques Used: Purification, Injection, Control, Flow Cytometry, Two Tailed Test



    Similar Products

    ot-i plus ot-ii peptides  (GenScript corporation)
    90
    GenScript corporation ot-i plus ot-ii peptides
    Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with <t>PBS</t> (Control), with both OT-I and OT-II <t>specific</t> <t>peptides</t> plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
    Ot I Plus Ot Ii Peptides, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ot-i plus ot-ii peptides/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    ot-i plus ot-ii peptides - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    ot-i plus ot-ii peptides  (MBL International)
    90
    MBL International ot-i plus ot-ii peptides
    Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with <t>PBS</t> (Control), with both OT-I and OT-II <t>specific</t> <t>peptides</t> plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.
    Ot I Plus Ot Ii Peptides, supplied by MBL International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ot-i plus ot-ii peptides/product/MBL International
    Average 90 stars, based on 1 article reviews
    ot-i plus ot-ii peptides - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.

    Journal: eLife

    Article Title: IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25 + Foxp3 - T cells

    doi: 10.7554/eLife.62432

    Figure Lengend Snippet: Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.

    Article Snippet: C57BL/6 mice were injected i.p. with PBS, OT-I plus OT-II peptides (10 and 50 μg/mouse, respectively; MBL International, Woburn, Massachusetts, USA; or Genscript, Piscataway, New Jersey, USA, respectively) plus polyI:C (75 μg/mouse; Sigma-Aldrich, St. Louis, Missouri, USA) or with the latter plus αIFN-γ mAb (250 μg/mouse; XMG1.2; BioXcell, Lebanon, New Hampshire, USA).

    Techniques: Purification, Injection, Control, Flow Cytometry, Two Tailed Test

    Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.

    Journal: eLife

    Article Title: IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25 + Foxp3 - T cells

    doi: 10.7554/eLife.62432

    Figure Lengend Snippet: Purified CD8 + and CD4 + T cells from OT-I/Ly5.1 and OT-II/Ly5.1 mice (2 and 4 × 10 6 /mouse respectively), were adoptively transferred (AT) to C56BL/6 mice. One day later, mice were i.p. injected with PBS (Control), with both OT-I and OT-II specific peptides plus polyI:C (75 µg/mice) or with the latter plus αIFN-γ mAb (250 µg). Expansion of AT T cells was determined 3 d post stimulation by flow cytometry. Dot plots showing one representative mouse ( A ) out of two mice analysed by flow cytometry and a bar graph showing mean ± SD ( B ) are presented. ( C ) Three groups of C56BL/6 mice described above and one control group (no AT) were challenged with LPS (50% of MNLD). ( D ) IFN-γ -/- and normal C56BL/6 mice (IFN-γ +/+ ) were treated with IL-2/JES6 and challenged with LPS (50% of MNLD) as shown in . IFN-γ -/- C56BL/6 mice challenged with the same dose of LPS were used as the control. ( E ) Data pooled from three independent experiments (n = 13–16 technical replicates) described in D showing body temperature of mice 8 h after LPS challenge. ( F ) Scheme showing the proposed mechanism of how IL-2/JES6 induces LPS hyperreactivity. Experiments A-D were done at least twice with similar results; n = 2–6 technical replicates. Data were analysed using unpaired two-tailed Student’s t-test. Significant differences to control are shown (* p ≤ 0.05; *** p ≤ 0.001). Figure 6—source data 1. Source data for , panels B-E.

    Article Snippet: C57BL/6 mice were injected i.p. with PBS, OT-I plus OT-II peptides (10 and 50 μg/mouse, respectively; MBL International, Woburn, Massachusetts, USA; or Genscript, Piscataway, New Jersey, USA, respectively) plus polyI:C (75 μg/mouse; Sigma-Aldrich, St. Louis, Missouri, USA) or with the latter plus αIFN-γ mAb (250 μg/mouse; XMG1.2; BioXcell, Lebanon, New Hampshire, USA).

    Techniques: Purification, Injection, Control, Flow Cytometry, Two Tailed Test